Relay Therapeutics RLAY
NASDAQ RLAY
$18.96 +0.47 (+2.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Selling, General & Administrative (2019 - 2026)

Updated

Relay Therapeutics (RLAY) recorded Selling, General & Administrative of $14.69 million in Q2 2026, up 7.8% from $13.63 million a year earlier and up 33.2% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Selling, General & Administrative (2019 - 2026) Analysis & Trends

On a TTM basis, Relay Therapeutics' Selling, General & Administrative came in at $50.06 million as of Jun 30, 2026, down 27.5% year-over-year; for FY2025, it was $56.71 million, down 26.0% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 8.0% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $76.59 million in FY2024 (+2.2%), $74.95 million in FY2023 (+13.6%), $65.98 million in FY2022 (+15.0%) and $57.39 million in FY2021 (+48.7%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q1 2025.
  • On a year-over-year basis, Selling, General & Administrative rose in three of the last eight quarters, with an average decline of 16.2%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 26.2% in Q1 2022, against a decline of 41.2% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $11.03 million (Q1 2026), $12.22 million (Q4 2025) and $12.13 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Relay Therapeutics 4.14 Bn 4.14 Bn - 14.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.69 Mn
Mar 31, 2026 11.03 Mn
Dec 31, 2025 12.22 Mn
Sep 30, 2025 12.13 Mn
Jun 30, 2025 13.63 Mn
Mar 31, 2025 18.74 Mn
Dec 31, 2024 16.90 Mn
Sep 30, 2024 19.75 Mn
Jun 30, 2024 20.14 Mn
Mar 31, 2024 19.80 Mn
Dec 31, 2023 16.77 Mn
Sep 30, 2023 18.49 Mn
Jun 30, 2023 20.12 Mn
Mar 31, 2023 19.58 Mn
Dec 31, 2022 16.37 Mn
Sep 30, 2022 16.07 Mn
Jun 30, 2022 17.47 Mn
Mar 31, 2022 16.07 Mn
Dec 31, 2021 15.55 Mn
Sep 30, 2021 14.68 Mn
API Access

Relay Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RLAY&period=max&api_key=YOUR_API_KEY